[Hyderabad, April 30th, 2025] – The global clinical nutrition market is experiencing a significant surge, projected to grow from USD 52.4 billion in 2023 to USD 89.7 billion by 2031, expanding at a CAGR of 6.9% ClearView Market Insights, 2024. This expansion is driven by increasing demand across three key sectors:

Request Sample @ https://clearviewmarketinsights.com/report-details/global-clinical-nutrition-market/

Aging Population and Chronic Diseases:

• Cancer Care: Specialized enteral nutrition products improve treatment tolerance, reducing hospital stays by up to 20%.
• Diabetes Management: Tailored formulas help regulate glycemic response, reducing HbA1c levels by an average of 1.2%.
• Geriatric Nutrition: Multinutrient supplements with muscle-preserving proteins slow sarcopenia progression by 30%.

Pediatric and Neonatal Nutrition:

• Preterm Infant Care: Human milk fortifiers enriched with DHA and ARA increase survival rates by 12%.
• Food Allergy Solutions: Hypoallergenic infant formulas are projected to see a 9.5% CAGR through 2030, driven by rising food sensitivity cases.
• Malnutrition Eradication: UNICEF-supported programs integrating ready-to-use therapeutic foods (RUTFs) aim to cut global child wasting rates by 25% by 2027.

Personalized and Precision Nutrition:

• Genetic Nutrition Profiling: Companies like Nutrigenomix offer DNA-based dietary recommendations improving treatment adherence by 40%.
• Microbiome-Targeted Formulas: Synbiotic supplements enhance gut health, with clinical trials showing 20% faster recovery post-antibiotic use.
• AI-Powered Meal Planning: Digital platforms design real-time diet adjustments based on continuous glucose monitoring (CGM) data.

2024 Breakthroughs

Commercialisation Milestones

Innovation Company Impact:

• Plant-Based Clinical Nutrition Nestlé Health Science 15% growth in dairy-free medical nutrition demand
• Microbiome Therapeutics Viome Launch of gut-targeted personalized supplements for cancer recovery
• 3D-Printed Nutritional Solutions Fit3D Customizable supplements for ICU patients, improving nutrient absorption rates by 25%

Investment & R&D Trends:

• Startup Funding: USD 2.8 billion raised in 2023, led by personalized nutrition and gut health startups.

Corporate R&D:

• Nestlé Health Science: USD 600M investment in microbiome therapies
• Abbott Laboratories: Expansion of precision nutrition portfolio with AI-integrated platforms

Executive Insights:

• "Precision nutrition will revolutionize patient care, allowing interventions that are truly individualized at the genetic and microbiome level."
  — Dr. Sophia Martinez, Chief Medical Officer, Abbott Nutrition
• "Clinical nutrition is no longer about just feeding patients—it's a front-line therapy against disease progression and hospital readmissions."
  — Prof. David Liu, Harvard Medical School, Department of Nutrition

Regional Analysis

• North America (XX% Market Share)
• Medicaid and Medicare reforms expanding nutrition coverage in oncology and chronic care management.
• Major hospital chains integrating personalized nutrition protocols to reduce readmissions.
• Europe (30% Share)
• EU Medical Device Regulation (MDR) expands definition of clinical nutrition products, enhancing regulatory oversight.
• Rising elderly population drives demand for enteral feeding solutions, especially in Germany, France, and Italy.
• Asia-Pacific (22% Share)
• China’s Healthy China 2030 Initiative promoting hospital nutrition programs.
• India’s government mandates nutrition support as part of public health insurance schemes.

Future Roadmap:

• 2025: Mainstream adoption of microbiome-based clinical nutrition in oncology treatment pathways.
• 2027: AI-driven predictive models for hospital malnutrition risk launched across top U.S. and EU hospitals.
• 2030: Full integration of personalized nutrition into electronic health records (EHRs) enabling real-time therapeutic adjustments.

Company Spotlight

• Nestlé Health Science:
• Market Position: 19% share in global clinical nutrition market.
• 2024 Innovation: Launch of plant-based enteral feeding solutions for chronic care settings.
• Growth Strategy: Strategic acquisitions of microbiome and personalized nutrition startups.

Abbott Laboratories

• Breakthrough: CGM-integrated nutrition planning for diabetes management.
• Partnerships: Collaboration with Dexcom and Medtronic for AI-based dietary management tools.

For more insights, visit https://clearviewmarketinsights.com/report-store

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-736